Skip to main content
. 2011 Dec 16;1(1):5. doi: 10.1007/s13554-011-0004-8

Table 1.

Summary of demographic and baseline characteristics of the intent-to-treat population in the AQ, Lyo, and Spanish studies.

AQ study* Lyo study Spanish study
Number of patients, n 45 51 70
Mean age at first visit, years (SD) 7.4 (2.8) 7.6 (2.6) 8.7 (2.4)
Male patients, n (%) 21 (47) 30 (59) 44 (63)
Mean height SDS at first visit (%) −2.99 (0.72) −3.21 (1.00)† −2.98 (0.60)‡
Mean weight at first visit, kg (SD) 20.1 (7.5) 19.9 (6.2) 23.8 (6.7)
Caucasian patients, n (%) 44 (100)§ 51 (100) 69 (99)
Patients with primary insufficiency of GH secretion, n (%) 44 (100)§ 51 (100) 68 (97)
Patients with secondary insufficiency of GH secretion, n (%) 0 (0) 0 (0) 2 (3)

*Group B of AQ study.

†Ferrández Longas reference.15

‡Prader et al reference.16

§One patient excluded for noncompliance at month 1.

GH=growth hormone; SDS=SD score.